blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1882691

EP1882691 - Quinuclidine derivatives as M3 antagonists [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.03.2009
Database last updated on 02.11.2024
Most recent event   Tooltip31.07.2009Change - representativepublished on 02.09.2009  [2009/36]
Applicant(s)For all designated states
CHIESI FARMACEUTICI S.p.A.
Via Palermo, 30
43100 Parma / IT
[2008/05]
Inventor(s)01 / Amari, Gabriele
Via Palermo 26/A
43100 Parma / IT
02 / Rizzi, Andrea
Via Palermo 26/A
43100 Parma / IT
03 / Patacchini, Riccardo
Via Palermo 26/A
43100 Parma / IT
04 / Cenacchi, Valentina
Via Palermo 26/A
43100 Parma / IT
05 / Villetti, Gino
Via Palermo 26/A
43100 Parma / IT
06 / Catena Ruiz, Juan Lorenzo
Via Palermo 26/A
43100 Parma / IT
07 / Masip Masip, Isabel
Via Palermo 26/A
43100 Parma / IT
 [2008/05]
Representative(s)Rambelli, Paolo, et al
Jacobacci & Partners S.p.A.
Corso Emilia 8
10152 Torino / IT
[N/P]
Former [2009/36]Rambelli, Paolo, et al
Jacobacci & Partners S.p.A. Corso Emilia 8
10152 Torino / IT
Former [2008/05]Rambelli, Paolo, et al
Corso Emilia 8
10152 Torino / IT
Application number, filing date06117883.626.07.2006
[2008/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1882691
Date:30.01.2008
Language:EN
[2008/05]
Search report(s)(Supplementary) European search report - dispatched on:EP12.04.2007
ClassificationIPC:C07D453/02, A61K45/06, A61P11/00
[2008/05]
CPC:
C07D453/02 (EP,KR,US); A61K45/06 (KR); A61P11/00 (EP);
A61P11/06 (EP); A61P11/16 (EP); A61P43/00 (EP)
Designated contracting states(deleted) [2008/41]
Former [2008/05]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Chinuclidinderivate als M3 Antagonisten[2008/05]
English:Quinuclidine derivatives as M3 antagonists[2008/05]
French:Dérivés de quinuclidine comme antagonistes M3[2008/05]
Examination procedure31.07.2008Application deemed to be withdrawn, date of legal effect  [2009/17]
09.09.2008Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2009/17]
Fees paidRenewal fee
25.07.2008Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DX]WO03053966  (S A L V A T LAB SA [ES], et al) [DX] 1-13 * page 1, lines 3-7 * * page 3, formula (I) * * examples 43,50 ** page 14, lines 19-21 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.